This HTML5 document contains 199 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n11http://dx.doi.org/10.18632/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q26741620
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в липні 2016 مقالة علمية (نشرت في 21-7-2016) 2016年论文 ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научни чланак 2017 թուականի Յունիսին հրատարակուած գիտական յօդուած wissenschaftlicher Artikel vitskapeleg artikkel articolo scientifico (pubblicato il 2016/07/21) 2016年論文 tudományos cikk bài báo khoa học vědecký článek publikovaný v roce 2016 artigo científico (publicado na 2016/07/21) 2016年论文 teaduslik artikkel artigo científico (publicado na 2017) article scientific מאמר מדעי wetenschappelijk artikel (gepubliceerd op 21.07.2016) επιστημονικό άρθρο vitenskapelig artikkel 2016年の論文 tieteellinen artikkeli 2016年論文 article científic 2016年论文 artikull shkencor научни чланак vedecký článok (publikovaný 2016/07/21) სამეცნიერო სტატია 2016年论文 научна статия artigo científico naučni članak мақолаи илмӣ article scientifique (publié 2016/07/21) 2017 թվականի հունիսին հրատարակված գիտական հոդված artículu científicu espublizáu en 2016 videnskabelig artikel (udgivet 2016/07/21) 2016年论文 artículo científico publicado en 2016 2016 nî lūn-bûn 2016年論文 scientific article 2016年論文 2016年论文 سائنسی مضمون vetenskaplig artikel articol științific scienca artikolo artikulong pang-agham mokslinis straipsnis 2016年論文 2016년 논문 บทความทางวิทยาศาสตร์ bilimsel makale مقالهٔ علمی мақолаи илмӣ научная статья artykuł naukowy
p:P577
wds:Q26741620-8526AE76-03F7-4655-9667-166A55ADF54D wds:Q26741620-FFCFA9D9-FC91-4F5E-B25B-5D6CD19E2217
wdt:P577
2016-07-21T00:00:00Z 2017-06-13T00:00:00Z
p:P407
wds:Q26741620-4269FB87-7867-405C-BA6A-C16E0AFBCEFA
wdt:P407
wd:Q1860
p:P2860
wds:Q26741620-3986FD57-0B12-4B06-89B4-934407729044 wds:Q26741620-41CB264D-F857-4CFE-990B-6A023185D7F4 wds:Q26741620-4E904836-BD4F-4C88-8571-94DD4E6D6CDA wds:Q26741620-58C79050-D5B0-4B0B-AD5D-E363227C76FB wds:Q26741620-5B6FF11F-5189-4112-8CE2-A3F0A15CCDA7 wds:Q26741620-5CF5BDBC-21EC-4164-B109-4A8B9B4FE603 wds:Q26741620-6600AE72-23B2-4919-93C7-9FB902FEFD6F wds:Q26741620-67C5D559-47CA-481C-A75C-B28C2186A3EE wds:Q26741620-763949F7-7F45-495C-8F4E-50356140A297 wds:Q26741620-793A9717-A004-4F85-9250-A98E10ADD372 wds:Q26741620-8E4BDC19-45FF-4138-B7C7-8FB4C01A3164 wds:Q26741620-91560616-47E1-41D0-966A-58631D67A21E wds:Q26741620-91C8713A-F5F5-42F5-A7BB-A70ECC2D7941 wds:Q26741620-94798B51-0073-4215-BADD-2E6D34F5FCEE wds:Q26741620-AA65A058-6C7F-4E0B-A62E-2D4745A87928 wds:Q26741620-AB302B52-3457-4B19-9823-261F510FE6AB wds:Q26741620-B22B518E-7E33-4051-9A62-56AC04BBC501 wds:Q26741620-BC0FA633-C5A2-441B-B949-6CE70BC9EEAD wds:Q26741620-CB5D1FA3-CDF0-4E49-B96E-B706850E68E2 wds:Q26741620-CBD13DEF-E0C5-436A-B2AA-7D0B5B1C3FF4 wds:Q26741620-CD3403AA-2932-4AAC-84C3-0FE8BA67DAE5 wds:Q26741620-CFC3A356-DA08-471C-A9DC-72487C98DA4C wds:Q26741620-D1E328E4-4744-4F3F-9E7E-A3AAF742077D wds:Q26741620-DE7C4D49-3351-40D2-8AB3-1B8A400833A9 wds:Q26741620-E0F0973D-EF3C-4E4D-B43F-1CBB7EAF41BD wds:Q26741620-F83F6DE0-2D7F-434A-B5E5-65DE0DEA40D9 wds:Q26741620-07CD0559-7BBE-43C1-BBB2-C8E4764D5822 wds:Q26741620-0B330293-7AE7-47A4-B722-1576FFF0C07E wds:Q26741620-14994E3C-029B-4A90-B89B-6CE21C9BC1AE wds:Q26741620-241073FB-3ABC-460D-8C00-9A4250F8911B wds:Q26741620-27ABD019-38AC-4C7E-8EE2-4D8D2463EAD4 wds:Q26741620-28168ACB-AAD1-46C0-BE09-9CDD522BA503 wds:Q26741620-35D0497A-4E0C-4D6C-9674-1EF8F88169DF wds:Q26741620-3603D907-4716-4D67-9C5F-059BC4C7E785
wdt:P2860
wd:Q40877337 wd:Q33386052 wd:Q33443411 wd:Q33348702 wd:Q34008578 wd:Q33409866 wd:Q33402536 wd:Q33410172 wd:Q33403690 wd:Q34291281 wd:Q44010411 wd:Q37655019 wd:Q69583295 wd:Q33391803 wd:Q57904272 wd:Q34008600 wd:Q39485433 wd:Q39062058 wd:Q35794132 wd:Q36467496 wd:Q37397995 wd:Q35571044 wd:Q33942495 wd:Q36274834 wd:Q33405602 wd:Q34753416 wd:Q33406135 wd:Q33410213 wd:Q44544763 wd:Q33416105 wd:Q33417670 wd:Q34549410 wd:Q33423168 wd:Q33412690
p:P2093
wds:Q26741620-6E0340EB-7985-48BB-A1D1-982AC5F580BF wds:Q26741620-75EBE66A-D5CB-4B94-8272-9C5DCB8C8809 wds:Q26741620-5146D0CD-AC00-48AA-B7B5-97C06680D53D wds:Q26741620-5404FD7C-6BF9-4D88-99B7-7AA1944440D9 wds:Q26741620-F20C0A05-0D15-4C9C-971E-98CD1FD05137 wds:Q26741620-E5912E8F-2B12-4ADF-A6CE-E2F629E7E105
wdt:P2093
Xiaoyan Ma Xuehong Ran Yandun Zou Haiying Yu Limei Fan Chunling Hu
rdfs:label
Carfilzomib/pomalidomide single-agent or in combination with other agents for the management of relapsed/refractory multiple myeloma : a meta-analysis of 37 trials Carfilzomib/pomalidomide single-agent or in combination with other agents for the management of relapsed/refractory multiple myeloma : a meta-analysis of 37 trials Carfilzomib/pomalidomide single-agent or in combination with other agents for the management of relapsed/refractory multiple myeloma : a meta-analysis of 37 trials
skos:prefLabel
Carfilzomib/pomalidomide single-agent or in combination with other agents for the management of relapsed/refractory multiple myeloma : a meta-analysis of 37 trials Carfilzomib/pomalidomide single-agent or in combination with other agents for the management of relapsed/refractory multiple myeloma : a meta-analysis of 37 trials Carfilzomib/pomalidomide single-agent or in combination with other agents for the management of relapsed/refractory multiple myeloma : a meta-analysis of 37 trials
schema:name
Carfilzomib/pomalidomide single-agent or in combination with other agents for the management of relapsed/refractory multiple myeloma : a meta-analysis of 37 trials Carfilzomib/pomalidomide single-agent or in combination with other agents for the management of relapsed/refractory multiple myeloma : a meta-analysis of 37 trials Carfilzomib/pomalidomide single-agent or in combination with other agents for the management of relapsed/refractory multiple myeloma : a meta-analysis of 37 trials
p:P1476
wds:Q26741620-FDCF8012-20BF-404D-A65A-B834C1D783BD
wdt:P1476
Carfilzomib/pomalidomide single-agent or in combination with other agents for the management of relapsed/refractory multiple myeloma : a meta-analysis of 37 trials
p:P304
wds:Q26741620-1AEB706D-8FAE-4277-AAEC-2C6BB95D4DD5
wdt:P304
39805-39817
p:P31
wds:Q26741620-9E50838E-ADFC-4B34-92CB-A4E882A47372 wds:Q26741620-A73DCD1C-C7CF-4507-A0AB-410DA972353A wds:Q26741620-4B2E3CBE-A49D-4432-A6B2-6251B2EB4016
wdt:P31
wd:Q13442814 wd:Q7318358 wd:Q815382
p:P921
wds:Q26741620-7E771E98-B50B-4CCA-A605-CA99D4C37D63 wds:Q26741620-8A49F893-AAF8-43F8-A11B-0E12DD33F1E3 wds:Q26741620-B7CD770A-016E-4EC1-A5CF-F7794944B3CB wds:Q26741620-9B5501E8-227D-437D-BA8C-7FA26420E656 wds:Q26741620-F5C680C6-1B87-4393-9AAB-AC802DA1C961 wds:Q26741620-E6426ECB-2045-4B5B-9B18-BC0961CB3C00
wdt:P921
wd:Q467635 wd:Q66764603 wd:Q17141389 wd:Q66615932 wd:Q13416904 wd:Q54945651
p:P698
wds:Q26741620-B707EE55-373B-46E3-96DB-313F4E271EBE
wdtn:P698
n12:27458170
wdt:P698
27458170
p:P1433
wds:Q26741620-DFB7EE2E-2444-4582-BCCC-B6528A4C0ACA
wdt:P1433
wd:Q1573155
p:P433
wds:Q26741620-05883525-983E-41DD-B6B1-65B59C4AE712
p:P478
wds:Q26741620-604E3FE9-891E-46A8-BBF7-E9D9DF192637
wdt:P433
24
wdt:P478
8
p:P356
wds:Q26741620-9AA41CED-E1EE-4EC2-82FF-67A4829EAE54
wdtn:P356
n11:ONCOTARGET.10768
wdt:P356
10.18632/ONCOTARGET.10768
p:P275
wds:Q26741620-EE71F92A-154C-4819-9BFC-18FDEAD12374
p:P5008
wds:Q26741620-659B5734-022B-4646-B2B7-7E05BE22B309
p:P6216
wds:Q26741620-03F132D6-3122-40EA-8452-94727DE6D7BF
wdt:P275
wd:Q14947546
wdt:P5008
wd:Q55439927
wdt:P6216
wd:Q50423863
p:P932
wds:Q26741620-424371F2-4CA5-4624-83E3-7BB51EB6BC37
wdt:P932
5503655